Dunaieva I. P.

ASSOCIATION BETWEEN 25-HYDROXYVITAMIN D AND METABOLIC DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION AND ASSOCIATED COMORBIDITIES

---

Show/Download

About the author:

Dunaieva I. P.

Heading:

CLINICAL AND EXPERIMENTAL MEDICINE

Type of article:

Scientific article

Annotation:

The results of several studies suggest a close relationship between 25-hydroxyvitamin D (25(OH)D) deficiency and the development of metabolic disorders. Given the global increase in the prevalence of cardiometabolic diseases, identifying the role of 25(OH)D as a potential predictor of carbohydrate and lipid metabolism is particularly relevant and warrants further investigation. Therefore, the present study aimed to assess the relationship between 25-hy droxyvitamin D (25(OH)D) levels and metabolic disorders in patients with arterial hypertension (AH), type 2 diabetes mellitus (T2DM), and obesity (OB). The study included 250 patients, divided into four clinical groups based on the combination of pathologies, as well as a control group. It was demonstrated that patients with comorbid patholo gy had statistically significantly lower 25(OH)D levels compared to healthy individuals. Correlation and regression analyses were performed, revealing inverse relationships between serum 25(OH)D levels and markers of insulin re sistance, including body mass index (BMI) and glycated haemoglobin (HbA1c). The most pronounced changes were observed in patients with concomitant AH, T2DM, and obesity. The identified associations confirm the role of vitamin D deficiency in the pathogenesis of metabolic imbalance, insulin resistance, and disturbances of carbohydrate and lipid metabolism. The findings of the study underscore the need to include serum 25(OH)D level assessment in car diometabolic risk screening programmes for individuals with comorbidities and highlight the potential importance of correcting this deficiency in the management of this patient group.

Tags:

Bibliography:

1. Bouillon R, Schuit F, Antonio L, Rastinejad F. Vitamin D Binding Protein: A Historic Overview. Front Endocrinol (Lausanne). 2020;10:910. DOI: 10.3389/fendo.2019.00910.
2. Trummer C, Schwetz V, Kollmann M, Wölfler M, Münzker J, Pieber TR, et al. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial. European Journal of Nutrition. 2019;58(5):2019-2028. DOI: 10.1007/s00394-018-1760-8.
3. Cătoi AF, Iancu M, Pârvu AE, Cecan AD, Bidian C, Chera EI, et al. Relationship between 25 hydroxyvitamin D, overweight/obesity status, pro-inflammatory and oxidative stress markers in patients with type 2 diabetes: a simplified empirical path model. Nutrients. 2021;13(8):2889. DOI: https://doi.org/10.3390/nu13082889.
4. Choi DP, Oh SM, Lee JM, Cho HM, Lee WJ, Song BM, et al. Serum 25-hydroxyvitamin D and insulin resistance in apparently healthy adolescents. PLoS One. 2014;9(7):e103108. DOI: 10.1371/journal.pone.0103108.
5.  Tkach SM, Pankiv VI, Pankiv IV. Suchasni pohlyady na metabolizm ta biolohichni efekty vitaminu D. Mizhnarodnyy endokrynolohichnyy zhurnal. 2022;18(2):109-117. DOI: 10.22141/2224-0721.18.2.2022.1156.
6.  Perna S. The enigma of vitamin D supplementation in aging with obesity. Minerva Gastroenterology. 2022;68(4):459-462. DOI: https://doi.org/10.23736/S2724-5985.21.02955-7.
7.  Holick M. F. Diabetes and the vitamin D connection. Current Diabetes Reports. 2008;8(5):393-398. DOI: https://doi.org/10.1007/s11892-008-0068-0.
8.  Lips P, Eekhoff M, van Schoor N, Oosterwerff M, de Jongh R, Krul-Poel Y, et al. Vitamin D and type 2 diabetes. Journal of Steroid Biochemistry and Molecular Biology. 2017;173:280-285. DOI: https://doi.org/10.1016/j.jsbmb.2016.11.021.
9.  Melguizo-Rodríguez L, Costela-Ruiz VJ, García-Recio E, De Luna-Bertos E, Ruiz C, Illescas-Montes R. Role of Vitamin D in the Metabolic Syndrome. Nutrients. 2021;13(3):830. DOI: https://doi.org/10.3390/nu13030830.
10.  Jayedi A, Daneshvar M, Jibril AT, Sluyter JD, Waterhouse M, Duarte Romero B, et al. Serum 25(OH)D concentration, vitamin D supplementation, and risk of cardiovascular disease and mortality in patients with type 2 diabetes or prediabetes: a systematic review and dose-response meta-analysis. The American Journal of Clinical Nutrition. 2023;118(3):676-693. DOI: https://doi.org/10.1016/j.ajcnut.2023.07.012.
11.  Dawson-Hughes B, Staten MA, Knowler WC, Nelson J, Vickery EM, LeBlanc ES, et al. Intratrial exposure to vitamin D and new-onset diabetes among adults with prediabetes: a secondary analysis from the Vitamin D and Type 2 Diabetes (D2d) study. Diabetes Care. 2020;43(12):2916-2922. DOI: https://doi.org/10.2337/dc20-1765.

Publication of the article:

«Bulletin of problems biology and medicine», Issue 2,177, 169-175 pages, index UDC 616.12-008.331.1+616.379-008.64]-056.257-008.9-078:577.161.2.088.6

DOI:

10.29254/2077-4214-2025-2-17 7-169-175